Sjs Investment Consulting Inc. Ironwood Pharmaceuticals Inc Transaction History

Sjs Investment Consulting Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$5.58 - $8.61 $111 - $172	-20 Reduced 80.0%	5 $0
Q4 2023 Jan 16, 2024	BUY	$8.79 - $11.51 $8 - $11	1 Added 4.17%	25 $0
Q3 2023 Oct 17, 2023	SELL	$8.25 - $11.35 $8 - $11	-1 Reduced 4.0%	24 $0
Q2 2023 Jul 13, 2023	SELL	$10.1 - $11.6 $80 - $92	-8 Reduced 24.24%	25 $0
Q1 2023 Apr 20, 2023	BUY	$10.37 - $12.56 $41 - $50	4 Added 13.79%	33 $0
Q4 2022 Jan 23, 2023	SELL	$9.9 - $12.43 $227 - $285	-23 Reduced 44.23%	29 $0
Q3 2022 Oct 13, 2022	BUY	$10.14 - $12.38 $486 - $594	48 Added 1200.0%	52 $0
Q1 2022 May 05, 2022	BUY	$10.61 - $12.88 $42 - $51	4 New	4 $0

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $527M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Sjs Investment Consulting Inc., based on Form 13F filings with the SEC.

Stay updated on Sjs Investment Consulting Inc. with notifications on news.